Regenerative medicine focuses on repairing damaged skin and bringing back melanocytes, the cells that give skin its color.

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.

Deramiocel is a cell therapy that has healing effects in muscle cells. If approved, deramiocel would be a once-quarterly ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

Vold, M.D., Ph.D., discusses how progressive pulmonary fibrosis is diagnosed in clinical practice, the barriers hindering early diagnosis, strategies to overcome these challenges and the critical role ...

Anna Podolanczuk, M.D., M.S., discusses how the differential diagnosis for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) is approached, the importance of early diagnosis ...

A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the ...

FDA officials have set a review date of June 30, 2025, to review avutometinib in combination with defactinib to treat ...

Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits.

This year’s top dermatology posts on Managed Healthcare Executive include stories about Gen Z sunscreen trends and increasing ...

Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...